Statement Of Cash Flows [Abstract]
| Concept |
2020-01-01 to 2020-12-31 |
2019-01-01 to 2019-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for deferred tax expense |
10,768,000
EUR
|
11,798,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
126,831,000
EUR
|
293,961,000
EUR
|
| Increase (decrease) in working capital |
77,885,000
EUR
|
49,347,000
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
38,360,000
EUR
|
30,502,000
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
120,965,000
EUR
|
50,711,000
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
10,334,000
EUR
|
0
EUR
|
| Adjustments for undistributed profits of investments accounted for using equity method |
4,883,000
EUR
|
1,334,000
EUR
|
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets |
668,760,000
EUR
|
244,009,000
EUR
|
| Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets |
5,046,000
EUR
|
153,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from issue of bonds, notes and debentures |
131,691,000
EUR
|
414,479,000
EUR
|
| Repayments of bonds, notes and debentures |
37,500,000
EUR
|
34,000,000
EUR
|